Integra LifeSciences has acquired Ascension Orthopedics for approximately $65 million in cash, according to a joint news release.
Ascension Orthopedics, a medical device company focusing on the lower and upper extremities, will represent approximately 45 percent of Integra's orthopedics revenue. The company will make a significant contribution to Integra's upper extremity and shoulder portfolio.
The acquisition also means Ascensions' differentiated pyrolytic carbon technology will be brought to Integra. The company's PyroCarbon is a specific form of carbon with manufactured crystalline structures for enhanced strength and wear characteristics.
Over the last 12 months ending in June, Ascension generated approximately $19 million.
Related Articles on Orthopedic Device Companies:
42 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in August
MedShape Solutions Receives Small Business Innovation Research Grant
Zimmer Supports Orthopedic Mission Trip to Nigeria
The acquisition also means Ascensions' differentiated pyrolytic carbon technology will be brought to Integra. The company's PyroCarbon is a specific form of carbon with manufactured crystalline structures for enhanced strength and wear characteristics.
Over the last 12 months ending in June, Ascension generated approximately $19 million.
Related Articles on Orthopedic Device Companies:
42 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in August
MedShape Solutions Receives Small Business Innovation Research Grant
Zimmer Supports Orthopedic Mission Trip to Nigeria